# Sunshine Biopharma Inc.: Form 8-K, filed Jun 7, 2024

- Company: [Sunshine Biopharma Inc.](/companies/sbfm.md) (CIK 1402328)
- Form: 8-K
- Filed: 2024-06-07
- Accepted by EDGAR: Jun 7, 2024, 16:00 ET
- Period: 2024-06-07
- Accession: 0001683168-24-004053
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1402328/000168316824004053/sunshine_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1402328/000168316824004053/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1402328/000168316824004053/sunshine_8k.htm

Filed Jun 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001683168-24-004053. Last ingested by Listed: Oct 27, 2026, 12:16 ET. No prices; not investment advice.